Eugene & Christine E Lynn Clinical Research is categorized under Hospitals in Boca Raton, FL and active since 2000.
Eugene & Christine E Lynn Clinical Research was established in 2000, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Hospitals business, which does work in the B2C market, and is classified as a Hospitals, under code number 622110 by the NAICS.
If you are seeking more information, feel free to contact Viviana Boronat at the company’s single location by writing to 701 Nw 13th St # 3004, Boca Raton, Florida FL 33486 or by phoning (561) 750-4800. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Eugene & Christine E Lynn Clinical Research |
Contact Person: | Viviana Boronat |
Address: | 701 Nw 13th St # 3004, Boca Raton, Florida 33486 |
Phone Number: | (561) 750-4800 |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 2000 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Hospitals |
SIC Code: | 8062 |
NAICS Code: | 622110 |
Share This Business: |
Eugene & Christine E Lynn Clinical Research was started in 2000 to provide professional Hospitals under the SIC code 8062 and NAICS code 622110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Viviana Boronat for inquiries that concern Eugene & Christine E Lynn Clinical Research by calling the company number (561) 750-4800, as your correspondence is most welcome. Additionally, the physical location of the single location of Eugene & Christine E Lynn Clinical Research can be found at the coordinates 26.361555,-80.101604 as well as the street address 701 Nw 13th St # 3004 in Boca Raton, Florida 33486.
For its online presence, you may visit Eugene & Christine E Lynn Clinical Research’s website at and engage with its social media outlets through on Twitter and on Facebook.